TROG Cancer Research is a global leader in radiotherapy research
TROG Cancer Research has been improving the way in which radiotherapy is delivered to cancer patients for almost 30 years.
Working with doctors and researchers from Australia and New Zealand, TROG Cancer Research conducts clinical trial research involving radiotherapy to treat many types of cancers such as breast, lung, prostate, skin, head and neck.
Radiotherapy controls and even cures various cancers using high energy x-rays. Our cutting-edge research is continually improving techniques and treatments for cancer patients.
Working together to improve cancer treatments
More than 14,500 people have volunteered for a TROG Cancer Research trial. To date TROG has conducted more than 100 clinical trials, helping our researchers to improve cancer treatments that impact on the outcome and quality of life for cancer patients.
TROG Cancer Research works in partnership with more than 70 hospital and cancer treatment centres across Australia and New Zealand.
Watch our latest TV community service announcement featuring our ambassador Julie McCrossin (radio broadcaster & journalist)
The Trans Tasman Radiation Oncology Group (TROG Cancer Research) is a registered charity with the Australian Charities and Not-for-Profits Commission.